This report outlines a proposed method for the development of cluster group comparators, based on socio-economic similarity and disease prevalence, to enable benchmarking of prescribing. The respiratory therapeutic area is used here to illustrate the method, due to the impact of respiratory illness on the population, the high cost of prescribing respiratory items, recent changes in the evidence base and the potential for prescribing review.
⇩ GP Cluster Level Comparators 514KB (PDF) |
(October 2014)